Shares of MetLife, Inc. (NYSE:MET - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eleven brokerages that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $95.60.
A number of equities analysts recently commented on the stock. Jefferies Financial Group lifted their price target on shares of MetLife from $100.00 to $103.00 and gave the stock a "buy" rating in a research note on Monday, August 11th. UBS Group dropped their price target on shares of MetLife from $94.00 to $91.00 and set a "buy" rating for the company in a research note on Thursday, August 7th. Keefe, Bruyette & Woods dropped their price target on shares of MetLife from $94.00 to $92.00 and set an "outperform" rating for the company in a research note on Monday, August 11th. Wall Street Zen cut shares of MetLife from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Morgan Stanley dropped their price target on shares of MetLife from $98.00 to $94.00 and set an "overweight" rating for the company in a research note on Monday, August 18th.
Check Out Our Latest Analysis on MET
MetLife Stock Down 0.4%
Shares of NYSE MET opened at $79.32 on Wednesday. The firm's 50-day moving average price is $78.21 and its 200-day moving average price is $78.33. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.57. The stock has a market capitalization of $52.75 billion, a price-to-earnings ratio of 13.44, a P/E/G ratio of 0.71 and a beta of 0.87. MetLife has a 12-month low of $65.21 and a 12-month high of $89.05.
MetLife (NYSE:MET - Get Free Report) last announced its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.32 by ($0.30). The business had revenue of $17.34 billion for the quarter, compared to analysts' expectations of $18.58 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. The firm's quarterly revenue was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.28 earnings per share. On average, equities research analysts anticipate that MetLife will post 9.65 EPS for the current fiscal year.
MetLife Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 9th. Investors of record on Tuesday, August 5th were paid a $0.5675 dividend. This represents a $2.27 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend was Tuesday, August 5th. MetLife's dividend payout ratio (DPR) is currently 38.47%.
Hedge Funds Weigh In On MetLife
A number of hedge funds have recently added to or reduced their stakes in MET. Norges Bank bought a new position in MetLife in the 2nd quarter worth about $756,104,000. Diamond Hill Capital Management Inc. bought a new position in MetLife in the 1st quarter worth about $336,965,000. Nuveen LLC bought a new position in MetLife in the 1st quarter worth about $312,946,000. ABN AMRO Bank N.V. bought a new position in MetLife in the 2nd quarter worth about $178,669,000. Finally, Price T Rowe Associates Inc. MD grew its stake in MetLife by 7.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,488,146 shares of the financial services provider's stock worth $2,126,734,000 after acquiring an additional 1,824,907 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.
About MetLife
(
Get Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.